外体miR-92a-3p调节结直肠癌中M2巨分化:对瘤迁移和血管生成的影响
Wei Zhao1, Yudan Wu2, Yixiao Wang1
1School of Basic Medical Sciences, Chengde Medical University, Chengde, China.
Medical oncology (Northwood, London, England)
|March 10, 2025
概括
结肠癌外体体中的microRNA miR-92a-3p通过准EID2B促进M2巨分化,增强瘤迁移和血管生成. 这一途径为结直肠癌治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 结肠直肠癌 (CRC) 是一个全球性的健康挑战.
- 大细胞两极分化,特别是M2型,在瘤微环境 (TME) 中显著影响CRC进展,转移和血管生成.
研究的目的:
- 为了研究miR-92a-3p在结肠癌衍生的外体细胞中的作用.
- 为了确定miR-92a-3p如何通过准EID2B来调节M2巨细胞极化.
- 阐明对CRC细胞迁移和血管生成的影响.
主要方法:
- 在CRC患者的血外体中进行微RNA表达差异分析 (GEO数据库,RT-qPCR).
- 异构体吸收可视化 (激光共聚焦显微镜).
- 宏细胞极化评估 (RT-qPCR,西布洛特).
- 下游目标识别 (生物信息学,双露西法酶记者检测).
- 分析MAPK/ERK路径.
主要成果:
- 在CRC患者的外体中,miR-92a-3p被上调,与淋巴结转移相关.
- miR-92a-3p促进了M0到M2的巨细胞两极分化.
- miR-92a-3p增强了CRC细胞的迁移,入侵和体外血管生成.
- miR-92a-3p的目标是EID2B,这与M2极化有负相关.
- miR-92a-3p激活了MAPK/ERK通路,从而诱导了M2极化.
结论:
- 结肠癌外体中的miR-92a-3p通过向EID2B和激活MAPK/ERK通路来促进M2巨分化.
- 这一过程增强了CRC细胞迁移和血管生成.
- miR-92a-3p代表了结直肠癌的潜在治疗标.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


